maternal obesity in pregnancy, gestational weight gain, and risk of childhood asthma
TRANSCRIPT
DOI: 10.1542/peds.2014-0439; originally published online July 21, 2014; 2014;134;e535Pediatrics
Erick Forno, Omar M. Young, Rajesh Kumar, Hyagriv Simhan and Juan C. CeledónChildhood Asthma
Maternal Obesity in Pregnancy, Gestational Weight Gain, and Risk of
http://pediatrics.aappublications.org/content/134/2/e535.full.html
located on the World Wide Web at: The online version of this article, along with updated information and services, is
of Pediatrics. All rights reserved. Print ISSN: 0031-4005. Online ISSN: 1098-4275.Boulevard, Elk Grove Village, Illinois, 60007. Copyright © 2014 by the American Academy published, and trademarked by the American Academy of Pediatrics, 141 Northwest Pointpublication, it has been published continuously since 1948. PEDIATRICS is owned, PEDIATRICS is the official journal of the American Academy of Pediatrics. A monthly
at UNIVERSITY OF TOLEDO LIBRARIES on September 30, 2014pediatrics.aappublications.orgDownloaded from at UNIVERSITY OF TOLEDO LIBRARIES on September 30, 2014pediatrics.aappublications.orgDownloaded from
Maternal Obesity in Pregnancy, Gestational WeightGain, and Risk of Childhood Asthma
abstractBACKGROUND AND OBJECTIVE: Environmental or lifestyle exposures inutero may influence the development of childhood asthma. In this meta-analysis, we aimed to assess whether maternal obesity in pregnancy(MOP) or increased maternal gestational weight gain (GWG) increasedthe risk of asthma in offspring.
METHODS: We included all observational studies published until Octo-ber 2013 in PubMed, Embase, CINAHL, Scopus, The Cochrane Database,and Ovid. Random effects models with inverse variance weights wereused to calculate pooled risk estimates.
RESULTS: Fourteen studies were included (N = 108 321 mother–childpairs). Twelve studies reported maternal obesity, and 5 reported GWG.Age of children was 14 months to 16 years. MOP was associated withhigher odds of asthma or wheeze ever (OR = 1.31; 95% confidenceinterval [CI], 1.16–1.49) or current (OR = 1.21; 95% CI, 1.07–1.37); each1-kg/m2 increase in maternal BMI was associated with a 2% to 3%increase in the odds of childhood asthma. High GWG was associatedwith higher odds of asthma or wheeze ever (OR = 1.16; 95% CI, 1.001–1.34). Maternal underweight and low GWG were not associated withchildhood asthma or wheeze. Meta-regression showed a negativeassociation of borderline significance for maternal asthma history(P = .07). The significant heterogeneity among existing studiesindicates a need for standardized approaches to future studies onthe topic.
CONCLUSIONS:MOP and high GWG are associated with an elevated riskof childhood asthma; this finding may be particularly significant formothers without asthma history. Prospective randomized trials ofmaternal weight management are needed. Pediatrics 2014;134:e535–e546
AUTHORS: Erick Forno, MD, MPH,a,b Omar M. Young, MD,b,c
Rajesh Kumar, MD,d Hyagriv Simhan, MD, MSCR,b,c andJuan C. Celedón, MD, DrPHa,b
aDivision of Pulmonary Medicine, Allergy, and Immunology,Children’s Hospital of Pittsburgh, Pittsburgh, Pennsylvania;bUniversity of Pittsburgh Medical School, Pittsburgh, Pennsylvania;cDivision of Maternal–Fetal Medicine, Magee-Womens Hospital,Pittsburgh, Pennsylvania; and dDivision of Allergy andImmunology, Lurie Children’s Hospital, Chicago, Illinois
KEY WORDSchildhood asthma, asthma risk factors, maternal obesity,gestational weight gain, meta-analysis
ABBREVIATIONSCI—confidence intervalCINAHL—Cumulative Index to Nursing and Allied Health LiteratureGWG—gestational weight gainMOP—maternal obesity in pregnancyOR—odds ratioSTROBE—Strengthening the Reporting of Observational Studiesin EpidemiologyTNF-a—tumor necrosis factor a
Dr Forno formulated the idea for the study and participated inthe study design, literature searches, study selection, dataabstraction, analysis, and interpretation and the writing of themanuscript; Dr Young participated in the study design, literaturesearches, study selection, data abstraction, analysis, andinterpretation and the writing of the manuscript; Dr Kumarparticipated in the data interpretation and the writing of themanuscript; Dr Simhan contributed to the data analysis andinterpretation and participated in the writing of the manuscript;Dr Celedón contributed to the data analysis and interpretationand participated in the writing of the manuscript; and allauthors approved the final manuscript as submitted. Dr Fornoand Dr Young contributed equally to this manuscript.
This trial has been registered at PROSPERO (www.crd.york.ac.uk/prospero) (identifier CRD42013005490).
www.pediatrics.org/cgi/doi/10.1542/peds.2014-0439
doi:10.1542/peds.2014-0439
Accepted for publication May 6, 2014
Address correspondence to Erick Forno, MD, MPH, Children’sHospital of Pittsburgh, 4401 Penn Avenue, Rangos ResearchBuilding #9130, Pittsburgh, PA 15224. E-mail: [email protected]
PEDIATRICS (ISSN Numbers: Print, 0031-4005; Online, 1098-4275).
Copyright © 2014 by the American Academy of Pediatrics
(Continued on last page)
PEDIATRICS Volume 134, Number 2, August 2014 e535
REVIEW ARTICLE
at UNIVERSITY OF TOLEDO LIBRARIES on September 30, 2014pediatrics.aappublications.orgDownloaded from
Obesity is a major public health prob-lem, affecting .35% of the adult pop-ulation in the United States1 andcomplicating up to 20% of pregnanciesin this country.1 Maternal obesity isdefined as a BMI $30 kg/m2, and ma-ternal overweight is defined as a BMIbetween 25 and 29.9 kg/m2.2 Maternalobesity is further stratified into clas-ses: class I (BMI 30–34.9), class II (BMI35–39.9), and class III (BMI $40).3
Maternal obesity in pregnancy (MOP)has been associated with adversepregnancy outcomes, including hy-pertensive disorders of pregnancy,gestational diabetes, and need for op-erative delivery.4,5 Maternal obesityalso has a significant impact on fetaldevelopment, the neonatal period, andoverall childhood development. It hasbeen associated with an elevated in-cidence of fetal neural tube defectssuch as spina bifida and anencephaly.6,7
Moreover, higher gestational weightgain (GWG) increases the risk of smallsize for gestational age and of iatro-genic preterm birth.8
In recent years, there has been grow-ing interest on how in utero expo-sures predispose infants to diseasesthroughout the life span. For example,British epidemiologist David Barker9
reported that people with a history oflow birth weight were at elevated riskof coronary artery disease later in lifeand, in what came to be known as theBarker hypothesis,10 theorized that theorigins of complex diseases may stemfrom intrauterine exposures. Thus,MOP may significantly affect life exutero for years to come. Given thesubstantial impact of maternal obesityon not only maternal but also fetal andneonatal outcomes, in 2009 the In-stitute of Medicine3 recommended thatobese women limit their GWG to be-tween 11 and 20 pounds.
Asthma, a complex disease that affects∼7 million children in the UnitedStates,11 can result from interactions
between hereditary and environmentalfactors12,13 beginning in utero. For ex-ample, maternal smoking during preg-nancy increases the risk of asthmain offspring14 and may hinder age-dependent improvement in airwayhyperreactivity among children withasthma.15
Along these lines, there is growing ev-idence that MOP or high GWG is asso-ciated with elevated risk of asthma orwheeze (a symptom of asthma) in off-spring.16–18 It is thought that in uteroexposure to different dietary patternsor to the proinflammatory milieu ofobesity may affect fetal immune orpulmonary development, thus leadingto asthma.17 Therefore, the aims of thismeta-analysis were to quantitativelyestimate the effect of MOP or GWG onchildhood asthma or wheeze, to gen-erate a pooled analysis of studiesavailable in the literature, and to ex-plore factors that maymodify the effectof MOP on childhood asthma.
METHODS
We prospectively registered the proto-col for this meta-analysis in PROSPEROon September 5, 2013: http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42013005490.
Sources and Study Selection
We searched PubMed, Embase, Cumu-lative Index to Nursing and Allied HealthLiterature, Scopus, the Cochrane Da-tabase, and Ovid for observationalstudies evaluating the association be-tween MOP or GWG and asthma orwheeze in childhood, published up toOctober 2013. Initial inclusion criteriawere as follows:
� Study design: Observational stud-ies published in English (or in lan-guages other than English whenable to translate into English orwhen enough information wasavailable in an English abstractfor use in the data analysis).
� Population: Children in whom out-comes were measured betweenbirth and ,18 years of age. Moth-ers in whom BMI at the beginningof pregnancy was ascertained di-rectly or by report at some pointduring pregnancy or whose GWGwas ascertained directly or by re-port in the third trimester of preg-nancy.
� Outcomes: Wheeze or asthma dur-ing childhood, determined by re-port, doctor’s diagnosis, medicalrecord review, or evaluation bythe study team. When .1 timepoint for such assessment existed,only the latest point available wasincluded.
Two authors (E.F. and O.M.Y.) in-dependently retrieved and screened allstudies according to these pre-determined selection criteria. In addi-tion, we manually screened referencesin the selected articles for additionalrelevant studies. Initial selection wasbased on title and abstract screening,and final selection was performed us-ing full texts. Exclusion criteria wereineligible study design (eg, interven-tional study for management of MOP orGWG or for prevention of childhoodasthma or wheeze), ineligible pop-ulation (eg, adults), ineligible outcomes(eg, other than childhood asthma orwheeze), and insufficient information inEnglish to determine inclusion criteriaand abstract risk estimates. Differ-ences of opinion for inclusion wereresolved by discussion.
Data Extraction and QualityAssessment
Using a uniform data extraction form,2 of the authors (E.F. and O.M.Y.) in-dependently extracted from full-textarticles all data on references (firstauthor, year of publication), number ofparticipants, timing of MOP or GWGdetermination (eg, gestational age atwhich “final” maternal weight was
e536 FORNO et al at UNIVERSITY OF TOLEDO LIBRARIES on September 30, 2014pediatrics.aappublications.orgDownloaded from
ascertained), BMI or GWG (means orcategories) as reported by the originalstudies, outcome definitions, ages atwhich outcomes were measured, totalnumber of participants, number ofparticipants with and without the out-comes when available, odds ratios(ORs) or risk ratios with their corre-sponding confidence intervals (CIs),and relevant covariates as reported inthe original studies (eg, mean mater-nal age, race, smoking exposure duringpregnancy or childhood). Disagree-ments on data extraction between the 2authors were resolved through mutualdiscussion and, if needed, consultationwith a third author (J.C.C.). Agreementbetween the reviewers on study selec-tion was determined by using theCohen k statistic (k). The quality ofreporting in the included studies wasassessed by using the Strengtheningthe Reporting of Observational Studiesin Epidemiology (STROBE) statementchecklist.19 Studies were graded as A(.85% of STROBE criteria fulfilled), B(50–85%), or C (,50%).
Analysis
Data collected were pooled to generatesummary estimates; each study wasweighed by its inverse effect size vari-ant. To evaluate the association of MOPor GWG, we calculated ORs for the de-velopment of childhood asthma orwheeze. Many studies provided differ-ent categories for MOP and GWG;therefore, when possible we contactedthe corresponding authors of theoriginal studies to provide us withestimates for BMI and GWG (in kilo-grams) as continuous variables. Wetested for heterogeneity in resultsacross studies by using a Cochran Qstatistic; the I2 statistic was used toquantify the extent of true heteroge-neity. ORs and their CIs were calculatedby using random effects models. Eggertests were used to assess for potentialpublication bias. Subgroup analyses byoutcome definition and age group and
meta-regression analyses were con-ducted to explore potential sources ofheterogeneity and assess effect modi-fication by different covariates such asmaternal age, race, and smoking ex-posure. All analyses were performed inStata version 12 (Stata Corp, CollegeStation, TX), and a P of .05 was con-sidered statistically significant.
RESULTS
A total of 474 studies were identified(Fig 1): 398 from PubMed, 31 fromEmbase, 28 from Scopus, 7 from Cu-mulative Index to Nursing and AlliedHealth Literature, 1 from the CochraneDatabase, and 9 from Ovid; no addi-tional references were identified fromreviewing references in relevant arti-cles. Of these, 14 studies with a total of108 321 mother–child pairs were in-cluded in the meta-analysis16–18,20–30
(Table 1). There was complete agree-
ment on 469 of 474 articles after titleand abstract screening (interreaderagreement k = .90) and on 40 of 42articles after full-text screening (k =.89).
Characteristics of Included Studies
Included studies were published be-tween March 1996 and October 2013.Twelve studies reported maternal BMI(continuous or categorical) closelybefore or at the beginning of preg-nancy16–18,20–23,25–27,29,30 and were in-cluded in the analysis of MOP; 5 studieswere included in the analysis ofGWG.20,21,23,24,28 Although many studiescategorized MOP and GWG in differentways, response from the authors of theoriginal studies was very positive, andthe majority of them provided us withestimates for continuous BMI18,20–23,27
and GWG (in kilograms)20,21 (or kindlyresponded that continuous data were
FIGURE 1Flowchart of study selection. k indicates Cohen’s k agreement coefficient (1.0 = perfect agreement).(Flowchart adapted from the Preferred Reporting Items for Systematic Reviews and Meta-AnalysesStatement for systematic reviews and meta-analyses.50)
REVIEW ARTICLE
PEDIATRICS Volume 134, Number 2, August 2014 e537 at UNIVERSITY OF TOLEDO LIBRARIES on September 30, 2014pediatrics.aappublications.orgDownloaded from
TABLE1
Characteristicsof
StudiesIncluded
intheMeta-analysis
Reference
NAgeofChildrenat
Outcom
eCityor
Country
Ascertainm
entof
Exposure;Outcome
Risk
Estim
ates
asOriginally
Reported
Comments
Quality
Scorea
Caudrietal2013
163963
8y
Netherlands
Self-report;self-
report
Persistent
wheeze:Continuous
prepregnancy
BMI,OR
=1.26
(CI,1.01–1.57).
Adjusted
forgender,parentalallergy,sm
oke
exposure,breastfeeding,daycare,pregnancy
duration,oldersiblings,birthwt,maternalage,
studyregion,parentaleducation,andmaternal
asthma.
A
Guerra
etal2013
171107
14mo
Spain
Self-report
Frequent
wheeze:Continuous
BMI,
OR=1.08
(CI,1.01–1.15).BM
Icategories:BMI,
18.5,OR=1.7
(CI,0.3–8.3);BMI25–30,OR=1.0
(CI,0.4–2.6);BMI.
30,OR=4.2
(CI,1.5–11.3).
Adjusted
formaternalsocioeconom
icstatus,
child’sgender
andwtfor
length,typeof
delivery,pretermbirth,birthwt,daycare,
breastfeeding,maternalage,parity,and
smoking,andparentalasthma.
A
Håberg
etal2009
1832
281
18mo
Norw
aySelf-report;
self-report
Wheeze:BM
Icategories:BM
I25–30,
RD=0.4(CI,–1.1,1.8);BMI.
30,
RD=3.3(CI,1.2,5.3).
Adjusted
formaternalage,parity,education,
income,asthma,andsm
okinginpregnancy,
parentalsm
okingafterbirth,breastfeeding,
daycare,child’sgender,low
birthwt,preterm
birth,andcesarean
section.Continuous
data
obtained
directlyfrom
theauthor.
A
Halonenetal2013
20261
9y
UnitedStates
(Tucson,
AZ)
Medicalrecords;
measured
Asthma:Prepregnancy
BMItertiles:
Middletertile
OR=0.5(CI,0.2–1.3);
high
OR=0.4(CI,0.2–1.1).GWG
categories:HighGW
G,OR
=3.4
(CI,1.6–7.2).
Adjusted
formaternalage,ethnicity,and
parity,
parentalsm
oking,andchild’sgender.
Continuous
dataobtained
directlyfrom
the
author.
A
Harpsøeetal2013
2138
874
7y
Denm
ark
Self-report;
self-report
Asthmaever:BMIcategories:BM
I,18.5,OR=1.03
(CI,0.88–1.22);
BMI25–30,OR=1.22
(CI,1.12–1.33);
BMI30–35,OR=1.56
(CI,1.36–1.79);
BMI.
35,OR=1.55
(CI,1.23–1.95).
Adjusted
formaternalage,race,socioeconomic
status,smokingduring
pregnancy,atopy,day
careuse,atopy,cesarean
delivery,child
gender,
andnumberofsiblings.Continuous
data
obtained
directlyfrom
theauthor.
A
GWGcategories:,
5kg,OR=1.17
(CI,0.94–1.45);5–9kg,OR=1.02
(CI,0.91–1.15);16–19
kg,OR=0.97
(CI,0.89–1.06);20–24
kg,OR=1.15
(CI,1.05–1.27);.25
kg,OR=1.19
(CI,1.04–1.35).
Currentasthma:BM
Icategories:BM
I,18.5,OR=1.07
(CI,0.85–1.34);BM
I25–30,OR=1.24
(CI,1.10–1.38);BM
I30–35,OR=1.58
(CI,1.32–1.90);
BMI.
35,OR=1.48
(CI,1.08–2.04).
GWGcategories:,
5kg,OR=0.84
(CI,0.60–1.17);5–9kg,OR=1.11
(CI,0.96–1.29);16–19
kg,OR=0.90
(CI,0.80–1.02);20–24
kg,OR=1.15
(CI,1.01–1.31);.25
kg,OR=1.23
(CI,1.03–1.46).
e538 FORNO et al at UNIVERSITY OF TOLEDO LIBRARIES on September 30, 2014pediatrics.aappublications.orgDownloaded from
TABLE1
Continued
Reference
NAgeofChildrenat
Outcom
eCityor
Country
Ascertainm
entof
Exposure;Outcome
Risk
Estim
ates
asOriginally
Reported
Comments
Quality
Scorea
Kumar
etal2010
221191
3y
UnitedStates
(Boston,
MA)
Self-report
Recurrentw
heezing:BM
Icategories:
BMI25–30,OR=1.58
(CI,0.75–3.30);
BMI.
30,OR=3.51
(CI,1.68–7.32).
Adjusted
formaternalage,race,education,atopy,
child’sgender,prematuredelivery,sm
oking
during
pregnancyandathome,fetalgrowth
retardation,andlargesizeforgestationalage.
Continuous
dataobtained
directlyfrom
the
author.
A
Leermakersetal2013
234656
4y
Netherlands
Self-report;
measured
Currentwheeze:
Studyincluded
2subgroups.Adjusted
for
maternalage,parity,ethnicity,education,
smokingduring
pregnancy,pets,gestational
complications,gestationalage
atmeasurement,child’sgender,gestationalage
atbirth,birthwt,breastfeeding,daycare,and
child’sheight
andwtatfollow-up.Continuous
dataobtained
directlyfrom
theauthor.
ANo
family
history:Continuous
BMI,
OR=1.02
(CI,0.95–1.08).Categories:
BMI,
20,OR=0.93
(CI,0.79–1.09);
BMI25–30,OR=1.09
(CI,0.95–1.26);
BMI.
30,OR=0.93
(CI,0.73–1.19).
Continuous
GWGOR
=1.10
(CI,
1.03–1.16).
Positivefamily
history:Continuous
BMI,
OR=1.06
(CI,0.98–1.43).Categories:
BMI,
20,OR=1.19
(CI,0.98–1.43),
BMI25–30,OR=0.95
(CI,0.80–1.14),
BMI.
30,OR=1.41
(CI,1.06–1.87).Continuous
GWG,OR
=1.09
(CI,1.01–1.17).
Olivetietal1996
24262
4–9y
UnitedStates
(Cleveland,OH)
Medicalrecords
Asthma:GW
Gcategory
(,9kg):
OR=3.42
(CI,1.72–6.79).
Adjusted
formaternalasthm
ahistory,
bronchiolitis,m
aternalsmoking,lack
ofprenatalcare,use
ofoxygen
atbirth,
prem
aturity,low
birthwt,
2500
g,and5-min
Apgarscore.
B
Pateletal20122
56945
15–16
yNorthern
Finland
Medicalrecords
Wheezeever:BMIcategoriesforwheeze
(ever)or
asthma(ever):BMI,
18.5,
OR=0.80
(CI,0.58–1.09);BM
I25–30,
OR=1.18
(CI,0.95–1.47);BM
I,30,
OR=0.99
(CI,0.66–1.48).Continuous
BMI,OR
=1.028(CI,1.005–1.051).
Adjusted
forsocioeconomicstatus,m
arital
status,m
aternaleducation,maternalasthm
a,birthwt,parentalsm
okingduring
gestation,
andadolescent
BMIatage
15y.
A
Currentwheeze:BM
Icategoriesfor
wheeze(current)or
asthma(current):
BMI,
18.5,OR=0.87
(CI,0.57–1.04);
BMI25–30,OR=1.13
(CI,0.85–1.30);
BMI,
30,OR=1.54
(CI,0.97–2.44).
Continuous
BMI,OR
=1.047
(CI,1.019–1.077).
Pike
etal2013
26940
6y
UnitedKingdom
Measured
Continuous
BMI:
Adjusted
formaternaleducation,asthma,
smokinginpregnancy,parity,child’sgender,
birthwt,breastfeeding,andotheroutcom
e-specificcovariates.
AAsthmaever:OR=1.06
(CI,0.91–1.24).
Currentasthma:OR
=1.10
(CI,0.92–1.32).
Wheezeever:OR=1.08
(CI,1.02–1.13).
Currentwheeze:OR
=1.02
(CI,0.87–1.20).
REVIEW ARTICLE
PEDIATRICS Volume 134, Number 2, August 2014 e539 at UNIVERSITY OF TOLEDO LIBRARIES on September 30, 2014pediatrics.aappublications.orgDownloaded from
not available28). For prepregnancy BMI,7 studies used maternal self-report ofheight or weight,16–18,21–23,29 and 5 usedmedical records or directly measuredboth.20,25–27,30 For GWG, 4 studies usedthe difference between weight in thethird trimester and that in the first tri-mester,20,23,24,28 and 1 used maternalreport of weight gain.21 Outcomesreported varied and includedwheezing (ever, current, transient, orpersistent) and asthma (ever orcurrent); 12 studies used self-report(of which 3 studies specified “reportof physician-diagnosed asthma”20,21,27),and 2 studies reported using physi-cian diagnosis or medical record re-view.22,24 For comparability purposes,we grouped (when possible) the out-comes into 2 broader categories:“asthma/wheeze ever”17,18,20–22,25–30 and“current asthma/wheeze.”21,23–26,29
Maternal Obesity During Pregnancy
Table 1 shows the original studies withthe MOP as reported (categorical orcontinuous) and the reported out-comes. Given heterogeneity of out-comes, we grouped them into “asthma/wheeze ever” and “current asthma/wheeze.” Figure 2 shows the pooledanalysis by BMI categories. Comparedwith children from mothers of normalweight, those whose mothers wereobese had higher odds of asthma orwheeze ever (OR = 1.49; 95% CI, 1.22–1.83; P , .001) and current asthma orwheeze (OR = 1.36; 95% CI, 1.08–1.68;P = .008). Maternal overweight showednonsignificant trends for asthmaor wheeze ever (OR = 1.13; 95% CI,0.99–1.29; P = .06) and current asth-ma or wheeze (OR = 1.11; 95% CI,0.98–1.25; P = .09). When analyzed to-gether, maternal overweight or obese(BMI .25) led to higher odds ofasthma or wheeze ever (OR = 1.31;95% CI, 1.16–1.49; P , .001) andcurrent asthma or wheeze (OR = 1.21;95% CI, 1.07–1.37; P = .003) (Supple-mental Figure 6). Maternal underweightTA
BLE1
Continued
Reference
NAgeofChildrenat
Outcom
eCityor
Country
Ascertainm
entof
Exposure;Outcome
Risk
Estim
ates
asOriginally
Reported
Comments
Quality
Scorea
Reichm
anand
Nepomnyaschy2008
271971
3y
UnitedStates
Medicalrecords
Asthmaever:BMI.
30,OR=1.34
(CI,1.03–1.76).
Adjusted
formaternalage,education,income,
race,smokingduring
pregnancy,parental
smoking,pretermdelivery,child
age,gender,
andBM
I.Continuous
dataobtained
directly
from
theauthor.
A
Rusconietal20072
815
609
6–7y
Italy
Self-report;self-
report
Persistent
wheezing:GW
G,9kg,OR=
1.08
(CI,0.84–1.39).GW
G.15
kg,
OR=1.20
(CI,0.98–1.48).
Adjusted
formaternalage,education,sm
oking,
studycenter,parentalasthm
aor
atopy,child
gender,low
birthwt,siblings,socioeconom
icstatus,season,andperson
who
completed
the
questionnaire.Authorrespondedbut
continuous
datanotavailable.
B
Scholtens
etal2010
293963
8y
Netherlands
Self-report
Continuous
BMI,no
family
history:
Adjusted
formaternaleducation,sm
oking,
asthma,breastfeeding,modeofdelivery,birth
wt,andchild’sBM
Iat8
yofage.
AAsthma:OR
=0.98
(CI,0.94–1.02).
Wheeze:OR
=1.01
(CI,0.69–1.07).
Continuous
BMI,positivefamily
history:
Asthma:OR
=1.05
(CI,1.01–1.10).
Wheeze:OR
=1.06
(CI,1.01–1.12).
Wrightetal20133
0261
2y
UnitedStates
(Boston,
MA)
Measured
Repeated
wheeze:BM
I.30,OR=2.65
(CI,1.01–6.95).
Adjusted
formaternalage,race,education,
prenatalsm
oking,atopy,child’sgender,birth
wtadjustedforgestationalage,and
serum
cortisollevels(afternoonslope).Continuous
dataunavailable.
A
Tableshow
scharacteristicsofindividualstudies,includingoutcom
e,obesity
categories,and
ORsas
definedandreported
intheoriginalmanuscript,as
wellasreported
covariates
used
intheiradjusted
models.
aQuality
ofreportingassessmentbasedon
STROBE
statem
entcriteria.19
e540 FORNO et al at UNIVERSITY OF TOLEDO LIBRARIES on September 30, 2014pediatrics.aappublications.orgDownloaded from
was not associated with asthma orwheeze (P = .71).
Figure 3 shows the pooled analysis ofmaternal BMI and asthma or wheeze.In this analysis, maternal BMI was sig-nificantly associated with higher oddsof asthma or wheeze ever (OR = 1.03per each 1 kg/m2 increase; 95% CI,
1.02–1.05; P , .001) and currentasthma or wheeze (OR = 1.02 per kg/m2;95% CI, 1.01–1.04; P = .009). There wassignificant heterogeneity for both out-comes (asthma or wheeze ever, I2 =70.4%; current asthma or wheeze,I2 = 66.3%). The Egger test showedthere could be significant publication
bias for asthma or wheeze ever (P = .04)but not for current asthma or wheeze(P = .99).
Gestational Weight Gain
Table 1 shows the original studies withGWG as reported (categories or con-tinuous). Figure 4 shows the pooled
FIGURE 2PooledanalysisbyBMIcategoriesandchildhoodasthmaorwheeze.MaternalobesitybyBMIcategorieswassignificantlyassociatedwithasthmaorwheezeeverand current asthmaorwheeze during childhood.Maternal overweight categories showednonsignificant trends toward increasedasthmaorwheeze. Note thatORs are for each category as comparedwith the “normal weight” category (BMI∼18.5–24.9). Some studies had 2 subgroups (with andwithout family history ofasthma or atopy) and may have 2 entries for the same weight category. Maternal underweight was not significantly associated with childhood asthma orwheeze.
REVIEW ARTICLE
PEDIATRICS Volume 134, Number 2, August 2014 e541 at UNIVERSITY OF TOLEDO LIBRARIES on September 30, 2014pediatrics.aappublications.orgDownloaded from
analysis by reported GWG categories.Children whose mothers were in thehigher GWG categories had signifi-cantly higher odds of asthma orwheeze ever (OR = 1.16; 95% CI, 1.001–1.34; P = .049) but not of currentasthma or wheeze (OR = 1.08; 95% CI,0.89–1.31; P = .45). Figure 5 shows thepooled analysis of maternal (continu-ous) GWG and asthma or wheeze. Inthis analysis, maternal GWG was sig-nificantly associated with higher oddsof current asthma or wheeze (OR =1.015 per 1-kg increase in GWG; 95% CI,1.01–1.02; P , .001) but not withasthma or wheeze ever (OR = 1.04 perkg; 95% CI, 0.97–1.11; P = .27). Both forGWG categories and for continuousGWG, the number of studies was small(n = 2–3). The Egger test showed nosignificant evidence of publication biasfor current asthma or wheeze (P = .52),but it could not be calculated forasthma or wheeze ever because of thesmall number of studies. SubnormalGWG was not associated with asthma
or wheeze (P = .19; Supplemental Fig-ure 7), but the number of studiesreporting was small (n = 3).
Subgroup Analysis andMeta-regression
Meta-regression was performed forBMI with covariates available for ex-traction fromtheoriginalstudies(at thestudy level [eg, mean or median ma-ternal age in the study] or at the cate-gory level when available [eg, mean ormedian maternal age within each BMIcategory in the study]). For continuousBMI, meta-regression showed a nega-tive association of borderline signifi-cance between maternal history ofasthma and the study effect size: Therisk of childhood asthma or wheezewith increasing maternal BMI washigherwhen theprevalenceofmaternalasthma was lower (b = 0.90; 95% CI,0.80–1.01; P = .07); this effect modifi-cation explained part of the study het-erogeneity (I2 decreased to 33.6%; R2 =81.5%). We were unable to perform
subgroup analysis or meta-regressionfor GWG because of the small numberof studies.
DISCUSSION
In this meta-analysis, we report thatchildren whose mothers were obeseduring pregnancy (defined by BMI cat-egories or by higher continuous BMI)are at higher risk of asthma or wheeze.Maternal underweight did not appearto increasetheriskofasthmaorwheezein childhood, although this analysisincluded only a few studies with smallsample sizes and may have been un-derpowered.
Maternal obesity could influence therisk of asthma in the offspring throughseveral mechanisms. Obesity is asso-ciated with a chronic, low-grade in-flammatory state.31 For example, it hasbeen associated with elevated levels ofinflammatory cytokines implicated inasthma, such as tumor necrosis factora (TNF-a), interleukin 6, and trans-forming growth factor b-1. Leptin,a proinflammatory adipokine, not onlyis elevated in the maternal circulationof pregnant obese women but also ishigher in the cord blood of their chil-dren than in children whose mothersare not obese.32 Conversely, adipo-nectin, which has antiinflammatoryproperties and has shown inverseassociations with asthma symptoms33
and airway inflammation,34 is de-creased in obesity and is also de-creased in newborns of obesemothers.35
Alternatively, maternal obesity mayinfluence the pathogenesis of asth-ma through exposure of the de-veloping fetus to different dietarypatterns.36 For example, obese womenare more likely to have low serum lev-els of vitamin D,37 andmaternal vitaminD insufficiency or deficiency has beenassociated with elevated risk of child-hood asthma.38 Similarly, maternalconsumption of other foods duringpregnancy (eg, meat, dairy, or fats) has
FIGURE 3Pooled analysis by continuous BMI and asthma or wheeze. Increasing maternal BMI was significantlyassociated with both asthma or wheeze ever and current asthma or wheeze during childhood. Note thatORs are for each unit increase in BMI. Some studies23,29 had 2 subgroups (with and without familyhistory of asthma or atopy) and may have 2 entries.
e542 FORNO et al at UNIVERSITY OF TOLEDO LIBRARIES on September 30, 2014pediatrics.aappublications.orgDownloaded from
been associated with childhoodasthma.39,40 Finally, shared geneticpolymorphisms or epigenetic changesas a result of maternal obesity could becausing, mediating, or modifying theelevated risk of asthma in their off-spring.
Individual studies assessing whethermaternal history of asthma modifiesthe effect of MOP on childhood asthmahave shown conflicting results.23,25,29
In our meta-regression analysis, therewas significant modification of the ef-fect of MOP on asthma by maternalasthma: There was a more pronouncedincrease in the risk of childhoodasthma when the prevalence of ma-ternal asthma was lower. Althoughsuch analysis is only exploratory andshould be interpreted with caution, itcould indicate that the risk conferred
by the mother’s asthma supersedesthat conferred by maternal obesity. Theheritability of asthma has been esti-mated to be ∼0.82–0.91,12,41 and stud-ies with higher prevalence of maternalasthma could be underpowered to de-tect an effect of maternal obesity. Al-ternatively, this finding may suggestthat the risk from maternal obesity isstronger for nonatopic asthma. Many42–44
but not all45 studies of obesity and asthmahave reported this association to bestronger among nonatopic children oradults.
GWG was reported in fewer studies.Although there seems to be a higherrisk of asthma or wheeze with higherGWG, the observed associations varieddepending on theway the exposurewasreported (categorical or continuousGWG) and the definition of asthma or
wheeze. GWG has also been associatedwith elevated maternal46,47 and cordblood47 leptin levels. Halonen et al20
reported that persistently elevatedTNF-a from birth to 3 months of agewas associated with asthma and de-creased lung function at age 9 yearsand that maternal GWG was the stron-gest predictor of an elevated TNF-alevel. These findings suggest that GWGand maternal obesity may contributeto the onset of childhood asthma viasimilar proinflammatory mechanisms.Additional studies are needed to reachmore definitive conclusions in regardto GWG and childhood asthma orwheeze.
Studies addressing maternal obesityand childhood asthma that did notmeetinclusion criteria for our meta-analysisshould be mentioned. In a Swedish
FIGURE 4Pooled analysis by GWG categories and asthma or wheeze. High maternal GWG was significantly associated with asthma or wheeze ever but not with currentasthma or wheeze (P = .47) during childhood. Note that categories of GWG vary between studies. Subnormal GWG was not significantly associated withchildhood asthma or wheeze (see Supplemental Fig 7).
REVIEW ARTICLE
PEDIATRICS Volume 134, Number 2, August 2014 e543 at UNIVERSITY OF TOLEDO LIBRARIES on September 30, 2014pediatrics.aappublications.orgDownloaded from
cohort of ∼431 000 first-born children,Lowe et al48 reported that MOP wasassociated with greater use of inhaledcorticosteroid use in boys and girls upto age 12 years and in girls up to age 16years; these results suggest that MOPmay also be a risk factor for more se-vere or persistent childhood asthma.Furthermore, in a study by Watson andMcDonald,49 both maternal baselineskinfold thickness (as a surrogate ofpercentage body fat) and increase inskinfold thickness during pregnancywere independently associated withgreater risk of asthma in childhood,whereas BMI was not significant. Theauthors proposed that skinfold mea-surement may be more sensitive thanBMI; this extends to maternal obesity inour recent report that for studies ofasthma, the child’s BMI may not be thebest or sole indicator of adiposity.45
The current study has several limi-tations. We included only articles pub-lished in English or with sufficientinformation in English to abstract datafor analysis, which may not fully rep-resent all studies conducted on thesubject. There was high variabilityamong studies. We dealt with this var-iability in 3 ways: To account for effectsize variability, we used random effectsmodels; to account for the variability inthe way BMI and GWG were categorizedin the original studies, we obtainedeffect sizes using continuous BMI orGWG from many of the authors of theoriginal reports; and we performedmeta-regression analyses to detectsignificant effectmodifiers. However, aswith anymeta-analysis,wewere limitedto the covariates available to us fromthe original articles. Finally, maternalobesity is also a risk factor for
childhood obesity, and the elevatedrisk of asthma could result partlyfrom the child’s own obesity; however,such confounding is unlikely giventhat most of the included studies ad-justed for birth weight16,17,22,23,25,26,29,30
or for the child’s weight or BMI atthe time of assessment of the out-come.17,23,25,27,29
CONCLUSIONS
We report that MOP is a significant riskfactor for the development of childhoodasthma or wheeze. GWG may also in-crease the risk of childhood asthmaor wheeze, but we were limited bythe small number of studies. The ef-fect of maternal obesity on childhoodasthmamay be more pronounced whenthe prevalence of maternal asthma islower.
FIGURE 5Pooled analysis by continuous GWG and asthma or wheeze. Increasing GWG (in kg) was significantly associated with current asthma or wheeze but not withasthma or wheeze ever (P = .27) during childhood. Note that ORs are for each 1-kg increase in GWG. Note the small number of studies in each outcome (n = 2).
e544 FORNO et al at UNIVERSITY OF TOLEDO LIBRARIES on September 30, 2014pediatrics.aappublications.orgDownloaded from
REFERENCES
1. Ogden CL, Carroll MD, Kit BK, Flegal KM.Prevalence of obesity among adults: UnitedStates, 2011–2012. NCHS Data Brief. 2013;131:1–8. PubMed PMID: 24152742
2. World Health Organization (WHO). Obesityand overweight: WHO. Fact sheet no. 311.2013. Available at: www.who.int/media-centre/factsheets/fs311/en/. AccessedApril 17, 2014
3. Institute of Medicine (IOM). Weight GainDuring Pregnancy: Reexamining theGuidelines. Washington, DC: National Acad-emy of Sciences, Institute of Medicine; 2009
4. Cedergren MI. Maternal morbid obesityand the risk of adverse pregnancy out-come. Obstet Gynecol. 2004;103(2):219–224
5. American College of Obstetricians andGynecologists. ACOG committee opinion no.549: obesity in pregnancy. Obstet Gynecol.2013;121(1):213–217
6. Waller DK, Mills JL, Simpson JL, et al. Areobese women at higher risk for producingmalformed offspring? Am J Obstet Gynecol.1994;170(2):541–548
7. Rasmussen SA, Chu SY, Kim SY, Schmid CH,Lau J. Maternal obesity and risk of neuraltube defects: a metaanalysis. Am J ObstetGynecol. 2008;198(6):611–619
8. Kiel DW, Dodson EA, Artal R, Boehmer TK,Leet TL. Gestational weight gain and preg-nancy outcomes in obese women: howmuch is enough? Obstet Gynecol. 2007;110(4):752–758
9. Barker DJ, Winter PD, Osmond C, MargettsB, Simmonds SJ. Weight in infancy anddeath from ischaemic heart disease. Lan-cet. 1989;2(8663):577–580
10. Paneth N, Susser M. Early origin of coro-nary heart disease (the “Barker hypothe-sis”). BMJ. 1995;310(6977):411–412
11. Akinbami LJ, Moorman JE, Bailey C, et al.Trends in asthma prevalence, health careuse, and mortality in the United States,2001–2010. NCHS Data Brief. 2012;94:1–8.PubMed PMID: 22617340
12. Thomsen SF, van der Sluis S, Kyvik KO,Skytthe A, Skadhauge LR, Backer V. In-crease in the heritability of asthma from1994 to 2003 among adolescent twins.Respir Med. 2011;105(8):1147–1152
13. Scirica CV, Celedón JC. Genetics of asthma:potential implications for reducing asthmadisparities. Chest. 2007;132(5 suppl):770S–781S
14. Gilliland FD, Li YF, Peters JM. Effects ofmaternal smoking during pregnancy andenvironmental tobacco smoke on asthma
and wheezing in children. Am J Respir CritCare Med. 2001;163(2):429–436
15. Cohen RT, Raby BA, Van Steen K, et al;Childhood Asthma Management ProgramResearch Group. In utero smoke exposureand impaired response to inhaled cortico-steroids in children with asthma. J AllergyClin Immunol. 2010;126(3):491–497
16. Caudri D, Savenije OEM, Smit HA, et alPerinatal risk factors for wheezing pheno-types in the first 8 years of life. Clin ExpAllergy. 2013;43(12):1395–1405
17. Guerra S, Sartini C, Mendez M, et al. Ma-ternal prepregnancy obesity is an inde-pendent risk factor for frequent wheezing ininfants by age 14 months. Paediatr PerinatEpidemiol. 2013;27(1):100–108
18. Håberg SE, Stigum H, London SJ, Nystad W,Nafstad P. Maternal obesity in pregnancyand respiratory health in early childhood.Paediatr Perinat Epidemiol. 2009;23(4):352–362
19. von Elm E, Altman DG, Egger M, Pocock SJ,Gøtzsche PC, Vandenbroucke JP; STROBEInitiative. The Strengthening the Reportingof Observational Studies in Epidemiology(STROBE) statement: guidelines for report-ing observational studies. J Clin Epidemiol.2008;61(4):344–349
20. Halonen M, Lohman IC, Stern DA, Ellis WL,Rothers J, Wright AL. Perinatal tumor ne-crosis factor-a production, influenced bymaternal pregnancy weight gain, predictschildhood asthma. Am J Respir Crit CareMed. 2013;188(1):35–41
21. Harpsøe MC, Basit S, Bager P, et al. Ma-ternal obesity, gestational weight gain, andrisk of asthma and atopic disease in off-spring: a study within the Danish NationalBirth Cohort. J Allergy Clin Immunol. 2013;131(4):1033–1040
22. Kumar R, Story RE, Pongracic JA, et al.Maternal pre-pregnancy obesity and re-current wheezing in early childhood. PediatrAllergy Immunol Pulmonol. 2010;23(3):183–190. PubMed PMID: 22375278. PubMed Cen-tral PMCID: 3281288
23. Leermakers ET, Sonnenschein-van der VoortAM, Gaillard R, et al. Maternal weight, gesta-tional weight gain and preschool wheezing.The Generation R Study. Eur Respir J. 2013;42(5):1234–1243. PubMed PMID: 23471348
24. Oliveti JF, Kercsmar CM, Redline S. Pre- andperinatal risk factors for asthma in innercity African-American children. Am J Epi-demiol. 1996;143(6):570–577
25. Patel SP, Rodriguez A, Little MP, et al.Associations between pre-pregnancy obe-
sity and asthma symptoms in adolescents.J Epidemiol Community Health. 2012;66(9):809–814
26. Pike KC, Inskip HM, Robinson SM, et al;Southampton Women’s Survey Study Group.The relationship between maternal adiposityand infant weight gain, and childhood wheezeand atopy. Thorax. 2013;68(4):372–379
27. Reichman NE, Nepomnyaschy L. Maternalpre-pregnancy obesity and diagnosis ofasthma in offspring at age 3 years. MaternChild Health J. 2008;12(6):725–733
28. Rusconi F, Galassi C, Forastiere F, et al.Maternal complications and procedures inpregnancy and at birth and wheezingphenotypes in children. Am J Respir CritCare Med. 2007;175(1):16–21
29. Scholtens S, Wijga AH, Brunekreef B, et al.Maternal overweight before pregnancy andasthma in offspring followed for 8 years.Int J Obes (Lond). 2010;34(4):606–613
30. Wright RJ, Fisher K, Chiu YH, et al. Dis-rupted prenatal maternal cortisol, mater-nal obesity, and childhood wheeze. Insightsinto prenatal programming. Am J RespirCrit Care Med. 2013;187(11):1186–1193
31. Fantuzzi G. Adipose tissue, adipokines, andinflammation. J Allergy Clin Immunol. 2005;115(5):911–919, quiz 920
32. Ferretti G, Cester A, Bacchetti T, et al. Leptinand paraoxonase activity in cord blood fromobese mothers [published online ahead ofprint October 23, 2013]. J Matern FetalNeonatal Med. 2013. PubMed PMID: 24147648
33. Kattan M, Kumar R, Bloomberg GR, et al.Asthma control, adiposity, and adipokinesamong inner-city adolescents. J Allergy ClinImmunol. 2010;125(3):584–592
34. Shore SA, Terry RD, Flynt L, Xu A, Hug C.Adiponectin attenuates allergen-inducedairway inflammation and hyperrespon-siveness in mice. J Allergy Clin Immunol.2006;118(2):389–395
35. Vega-Sanchez R, Barajas-Vega HA, Rozada G,Espejel-Nuñez A, Beltran-Montoya J, Vadillo-Ortega F. Association between adiposity andinflammatory markers in maternal and fetalblood in a group of Mexican pregnantwomen. Br J Nutr. 2010;104(12):1735–1739
36. Kumar R. Prenatal factors and the de-velopment of asthma. Curr Opin Pediatr.2008;20(6):682–687
37. Scholl TO, Chen X. Vitamin D intake duringpregnancy: association with maternalcharacteristics and infant birth weight.Early Hum Dev. 2009;85(4):231–234
38. Maslova E, Hansen S, Jensen CB, Thorne-Lyman AL, Strøm M, Olsen SF. Vitamin D
REVIEW ARTICLE
PEDIATRICS Volume 134, Number 2, August 2014 e545 at UNIVERSITY OF TOLEDO LIBRARIES on September 30, 2014pediatrics.aappublications.orgDownloaded from
intake in mid-pregnancy and child allergicdisease: a prospective study in 44,825Danish mother–child pairs. BMC PregnancyChildbirth. 2013;13(1):199
39. Chatzi L, Garcia R, Roumeliotaki T, et al;INMA Study Group; RHEA Study Group.Mediterranean diet adherence duringpregnancy and risk of wheeze and eczemain the first year of life: INMA (Spain) andRHEA (Greece) mother–child cohort stud-ies. Br J Nutr. 2013;110(11):2058–2068
40. Miyake Y, Tanaka K, Okubo H, Sasaki S,Arakawa M. Maternal fat intake duringpregnancy and wheeze and eczema inJapanese infants: the Kyushu Okinawa Ma-ternal and Child Health Study. Ann Epi-demiol. 2013;23(11):674–680
41. van Beijsterveldt CE, Boomsma DI. Geneticsof parentally reported asthma, eczema andrhinitis in 5-yr-old twins. Eur Respir J. 2007;29(3):516–521
42. Visness CM, London SJ, Daniels JL, et al.Association of childhood obesity with atopic
and nonatopic asthma: results from theNational Health and Nutrition ExaminationSurvey 1999–2006. J Asthma. 2010;47(7):822–829
43. Fenger RV, Gonzalez-Quintela A, Vidal C,et al. Exploring the obesity–asthma link: doall types of adiposity increase the risk ofasthma? Clin Exp Allergy. 2012;42(8):1237–1245
44. Telenga ED, Tideman SW, Kerstjens HA, et al.Obesity in asthma: more neutrophilic in-flammation as a possible explanation fora reduced treatment response. Allergy.2012;67(8):1060–1068
45. Forno E, Acosta-Perez E, Brehm J, et alObesity and adiposity indicators, asthma,and atopy in Puerto Rican children. JAllergy Clin Immunol. 2014;133(5):1308–1314
46. Ferraro ZM, Qiu Q, Gruslin A, Adamo KB.Excessive gestational weight gain andobesity contribute to altered expression ofmaternal insulin-like growth factor binding
protein-3. Int J Womens Health. 2013;5:657–665. PubMed PMID: 24124394. PubMedCentral PMCID: 3794982
47. Karakosta P, Georgiou V, Fthenou E, et al.Maternal weight status, cord blood leptinand fetal growth: a prospective mother–child cohort study (Rhea study). PaediatrPerinat Epidemiol. 2013;27(5):461–471
48. Lowe AJ, Ekeus C, Bråbäck L, Rajaleid K,Forsberg B, Hjern A. Impact of maternalobesity on inhaled corticosteroid use inchildhood: a registry based analysis of firstborn children and a sibling pair analysis.PLoS ONE. 2013;8(6):e67368
49. Watson PE, McDonald BW. Subcutaneousbody fat in pregnant New Zealand women:association with wheeze in their infants at18 months. Matern Child Health J. 2013;17(5):959–967
50. Moher D, Liberati A, Tetzlaff J, Altman DG;PRISMA Group. Preferred reporting itemsfor systematic reviews and meta-analyses:the PRISMA statement. BMJ. 2009;339:b2535
(Continued from first page)
FINANCIAL DISCLOSURE: The authors have indicated they have no financial relationships relevant to this article to disclose.
FUNDING: Dr Forno was supported by NIH grant K12-HD052892. Dr Celedón was supported by NIH grants HL079966 and HL117191 and an endowment from the HeinzFoundation. Funded by the National Institutes of Health (NIH).
POTENTIAL CONFLICT OF INTEREST: Dr Celedón served as a one-time consultant for Genentech in 2011 on an issue unrelated to this manuscript; the other authorshave indicated they have no potential conflicts of interest to disclose.
e546 FORNO et al at UNIVERSITY OF TOLEDO LIBRARIES on September 30, 2014pediatrics.aappublications.orgDownloaded from
DOI: 10.1542/peds.2014-0439; originally published online July 21, 2014; 2014;134;e535Pediatrics
Erick Forno, Omar M. Young, Rajesh Kumar, Hyagriv Simhan and Juan C. CeledónChildhood Asthma
Maternal Obesity in Pregnancy, Gestational Weight Gain, and Risk of
ServicesUpdated Information &
tmlhttp://pediatrics.aappublications.org/content/134/2/e535.full.hincluding high resolution figures, can be found at:
Supplementary Material
6/peds.2014-0439.DCSupplemental.htmlhttp://pediatrics.aappublications.org/content/suppl/2014/07/1Supplementary material can be found at:
References
tml#ref-list-1http://pediatrics.aappublications.org/content/134/2/e535.full.hat:This article cites 42 articles, 6 of which can be accessed free
Permissions & Licensing
tmlhttp://pediatrics.aappublications.org/site/misc/Permissions.xhtables) or in its entirety can be found online at: Information about reproducing this article in parts (figures,
Reprints http://pediatrics.aappublications.org/site/misc/reprints.xhtml
Information about ordering reprints can be found online:
rights reserved. Print ISSN: 0031-4005. Online ISSN: 1098-4275.Grove Village, Illinois, 60007. Copyright © 2014 by the American Academy of Pediatrics. All and trademarked by the American Academy of Pediatrics, 141 Northwest Point Boulevard, Elkpublication, it has been published continuously since 1948. PEDIATRICS is owned, published, PEDIATRICS is the official journal of the American Academy of Pediatrics. A monthly
at UNIVERSITY OF TOLEDO LIBRARIES on September 30, 2014pediatrics.aappublications.orgDownloaded from